印度目標在 2047 年實現 1 兆美元的生物經濟產值
India Targets $1 Trillion Bio-Economy by 2047
印度已啟動一項雄心勃勃的計畫，旨在將其生物經濟規模於2047年提升至1兆美元，並努力成為全球生物技術與永續創新的領導者。
India has launched an ambitious initiative to grow its bio-economy to $1 trillion by 2047, aiming to become a global leader in biotechnology and sustainable innovation.
如今，該領域對印度GDP的貢獻率達4.2%，並有清晰的藍圖以在2030年達到3000億美元。
Today, it contributes 4.2% to India's GDP, with a clear roadmap to reach $300 billion by 2030.
此成長的關鍵動力在於蓬勃發展的新創生態系統，在十多年間，其企業數量從50家爆發性增長至超過11,000家。
A key driver of this growth is the booming startup ecosystem, which has exploded from 50 companies to over 11,000 in just over a decade.
生物經濟由四大支柱支撐：生物工業、生物製藥、生物IT與生物農業。
The bio-economy is built on four pillars: BioIndustrial, BioPharma, BioIT, and BioAgri.
這些領域受到BioE3政策的支援，該政策推廣生物製造與「廢物變財富」模式。
These areas are supported by the BioE3 policy, which promotes biomanufacturing and waste-to-wealth models.
盡管印度致力於實現耐氣候的成長及淨零排放目標，但仍須解決監管瓶頸以及對專業人才培訓的需求。
While the nation aims for climate-resilient growth and net-zero targets, it must address challenges such as regulatory bottlenecks and the need for specialized workforce training.
通過轉型為以創新為導向的經濟體，印度尋求將先進研究與工業規模相結合，使其成為未來生物解決方案與全球永續性的核心樞紐。
By transitioning toward an innovation-led economy, India seeks to integrate advanced research with industrial scale, positioning itself as a central hub for future biological solutions and global sustainability.
